Home » Newsletters » BioWorld

BioWorld

Jan. 13, 1999

View Archived Issues

Other News To Note

Biogen's Avonex Sales Top $120M For Quarter

Connetics Signs $40M Deal With Second Relaxin Partner

Idun, Abbott Sign $30M Deal For Cancer Drugs

Complex Polygenic Metabolic Disorder Tracked To Gene Pathway In Rat

LeukoSite, Warner-Lambert Enter Inflammation Deal Worth Up To $100M

Aviron Nets $400M Deal With Wyeth-Ayerst

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 17, 2024.
Second insulin receptor offers new therapeutic avenues
BioWorld Science
Investigators at the Helmholtz Institute have shown that inceptor, an inhibitor of the insulin signaling pathway, acted by binding insulin and targeting it for...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.